Skip to main content

CME Group To Launch E-mini S&P Europe 350 ESG Index Futures

Derivatives exchange CME Group is launching E-mini S&P Europe 350 ESG Index futures, a targeted risk management tool to align with environmental, social and governance (ESG) values. The new product will be will be cash-settled in EUR and available for trading on May 24, pending regulatory review.

"Interest in ESG strategies continues to increase as financial institutions incorporate sustainable investing objectives into their trading strategies," said Tim McCourt, CME Group Global Head of Equity Index and Alternative Investment Products. "Futures products can be an important part of the solution. This latest addition to our ESG offerings will allow market participants in this region to gain exposure to a European index based on a robust ESG methodology - all to meet their risk management needs."

"S&P Dow Jones Indices is proud to be a part of the CME Group's launch of E-Mini futures based on our S&P Europe 350 ESG Index. We are excited that the ecosystem of financial products linked to our ESG indices is growing and diversifying as more investors incorporate sustainability targets in their strategies," said Reid Steadman, Global Head of ESG at S&P Dow Jones Indices. "CME Group's E-mini S&P Europe 350 ESG Index Futures complements the successful launch in the U.S. in 2019 of E-Mini futures tied to our S&P 500 ESG Index, enabling us to bring ESG principles to a broader group of global market participants." 

The S&P Europe 350 ESG Index is a broad-based, market-cap weighted index that is designed to measure the performance of securities meeting sustainability criteria, while maintaining similar overall industry group weights as the S&P Europe 350. This index incorporates S&P DJI ESG Scoring.


© The Sortino Group Ltd

All Rights Reserved. No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or scanning or otherwise, except under the terms of the Copyright, Designs and Patents Act 1988 or under the terms of a licence issued by the Copyright Licensing Agency or other Reprographic Rights Organisation, without the written permission of the publisher. For more information about reprints from AlphaWeek, click here.